Pharmacom Labs PHARMA Test E300 Lab Test Results

Pharmacom Labs PHARMA Test E300 is presented in a 10ml vial and reportedly contains 300 milligrams of testosterone enanthate per milliliter according to the label and packaging. Samples of this product were purchased from a European-based internet source between the dates of April 10, 2015 and May 10, 2015. The samples were forwarded and received by the analytical laboratory Simec AG for HPLC-UV testing on May 19, 2015. The quantitative dosage testing report was completed on June 2, 2015. The “quality code” listed on the product was 146b73cc4q. The quality code was successfully used to verify the product on pharmacomlabs.com/code.

Label claim: Pharmacom Labs PHARMA Test E300 has a label claim of 300 mg/ml testosterone enanthate.

Actual content: Pharmacom Labs PHARMA Test E300 was determined to have actual content of 306.05 mg/ml testosterone enanthate.

(The following images are photographs of the actual product that was submitted for testing.)

Pharmacom Labs PHARMA Test E300 (testosterone enanthate) - vial and quality code  Pharmacom Labs PHARMA Test E300 (testosterone enanthate) - expiration date Pharmacom Labs PHARMA Test E300 (testosterone enanthate) - vial and box Pharmacom Labs PHARMA Test E300 (testosterone enanthate) - quality code verified

Pharmacom Labs PHARMA Test E300 Dosage Quantification Lab Results [PDF]
Pharmacom Labs PHARMA Test E300 Dosage Quantification Lab Results [PDF]
How many milligrams of testosterone enanthate are really in each milliliter of Pharmacom Labs PHARMA Test E300? HPLC-UV (June 2, 2015) ...
Size467.73 KB
Downloaded2341 times
Last UpdatedFebruary 6, 2016
Download

4 thoughts on “Pharmacom Labs PHARMA Test E300 Lab Test Results”

  1. Seems strange if the primary goal in to ensure health and safety of UGL users. Surely the lab should also be testing for a whole host of other substances/contaminants which could be found in UGL injectables. A microbiotic and chemical contaminant test should also be performed as standard.

Leave a Comment